Published in Gene Therapy Weekly, November 3rd, 1997
But other AIDS researchers, responding to the announcement that the U.S. Food and Drug Administration (FDA) had approved safety trials of a new vaccine in human volunteers, said a successful vaccine against HIV was a long way off and no one should get his hopes up.
Julia Hurwitz and Karen Slobod of St. Jude Children's Research Hospital in Memphis, Tennessee, said their vaccine, which uses part of the protein coating of HIV, was meant to protect healthy people against infection...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.